Parkside Financial Bank & Trust’s Arcus Biosciences RCUS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.84K	Hold	85	–	–	﹤0.01%	2147
2025 Q4	$2.03K	Hold	85	–	–	﹤0.01%	2088
2025 Q3	$1.16K	Hold	85	–	–	﹤0.01%	2223
2025 Q2	$693	Buy	+85	New	+$726	﹤0.01%	2387
2024 Q4	–	Sell	-15	Closed	-$230	–	2180
2024 Q3	$230	Buy	15 +4	+36%	+$63	﹤0.01%	1988
2024 Q2	$168	Sell	11 -2	-15%	-$32	﹤0.01%	1970
2024 Q1	$246	Hold	13	–	–	﹤0.01%	1895
2023 Q4	$249	Sell	13 -139	-91%	-$2.22K	﹤0.01%	1901
2023 Q3	$2.73K	Hold	152	–	–	﹤0.01%	1563
2023 Q2	$3.09K	Hold	152	–	–	﹤0.01%	1546
2023 Q1	$2.77K	Sell	152 -11	-7%	-$210	﹤0.01%	1598
2022 Q4	$3.37K	Hold	163	–	–	﹤0.01%	1487
2022 Q3	$4K	Buy	163 +77	+90%	+$2.04K	﹤0.01%	1330
2022 Q2	$2K	Buy	+86	New	+$2.11K	﹤0.01%	1618

Other funds holding RCUS

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Parkside Financial Bank & Trust's RCUS Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Arcus Biosciences (RCUS) position steady in Q1 2026 at 85 shares worth $1.84K. The position accounts for ﹤0.01% of the portfolio, ranked #2147.

Parkside Financial Bank & Trust first reported a position in RCUS in Q2 2022 and has held it in 14 quarters since. The position peaked at $4K in Q3 2022. 210 funds tracked by Wall St. Rank hold RCUS as of Q1 2026.

Parkside Financial Bank & Trust held 85 shares of Arcus Biosciences worth $1.84K as of Q1 2026.
Parkside Financial Bank & Trust left its Arcus Biosciences share count unchanged in Q1 2026.
Arcus Biosciences made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2147 holding.
Parkside Financial Bank & Trust first reported a position in Arcus Biosciences in Q2 2022 and has held it in 14 quarters since.
Parkside Financial Bank & Trust's Arcus Biosciences position peaked at $4K in Q3 2022.
210 funds tracked by Wall St. Rank held Arcus Biosciences as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.